IPD cases by age and vaccine serotype coverage.
Gili Regev‐Yochay(Tel Aviv University), Ron Dagan(Ben-Gurion University of the Negev), Jacob Strahilevitz(Hebrew University of Jerusalem), Yonit Wiener‐Well(Shaare Zedek Medical Center), Michal Stein(Uniformed Services University of the Health Sciences), Daniel Glikman(Bar-Ilan University), Klaris Riesenberg(Ben-Gurion University of the Negev), Israel Potasman(Technion – Israel Institute of Technology), Galia Rahav(Unknown), Regina Weber(Carmel Medical Center)
Cited by 0
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576
Plasmid-Mediated Quinolone Resistance
|Microbiology Spectrum|2014|469